Indicators of minimal blood mobile counts are frequent during therapy with LYNPARZA, but can be a indicator of significant bone marrow challenges, which includes MDS or AML. Ahead of having LYNPARZA, tell your healthcare provider about all of your current clinical conditions, including in the event you: utilized exclusively by https://richardo123asj4.bmswiki.com/user